Projects and Grants per year
- 1 - 50 out of 84 results
Search results
-
Active
Metabolic Newborn Screening C5215 - FY25 Newborn Screening Services
Zarate, Y. (PI), Deniskin, R. (CoI), Fowlkes, J. (CoI), Kanga, J. (CoI) & Radulescu, V. (CoI)
KY Cabinet for Health and Family Services
7/1/24 → 6/30/26
Project: Research project
-
Cystic Fibrosis Center Program FY25 - Pediatrics Portion
Kanga, J. (PI), Ramdial, F. (CoI), Thomas, T. (CoI) & Wurth, M. (CoI)
7/1/24 → 6/30/25
Project: Research project
-
Therapeutic Development Center FY25
Wurth, M. (PI), Anstead, M. (CoI), Autry, E. (CoI), Cosentino Roa, M. (CoI), Kanga, J. (CoI), Kormelink, L. (CoI) & Ramdial, F. (CoI)
7/1/24 → 6/30/25
Project: Research project
-
Applying the ORBIT Model to Address Medical Trauma in Youth with CF
Marsac, M. (PI), Kanga, J. (CoI) & Wurth, M. (CoI)
6/1/23 → 5/31/25
Project: Research project
-
A Prospective Study Evaluating Maternal and FetaL Outcomes in the ERa of ModulatorS (MAYFLOWERS)
Anstead, M. (PI), Kanga, J. (CoI) & Danov, Z. (Former CoI)
Seattle Childrens Research Institute
4/1/21 → 2/15/26
Project: Research project
-
Characterizing CFTR Modulated Changes in Sweat Chloride and Clinical Outcomes
Kanga, J. (PI) & Pancham, K. (Former PI)
Seattle Childrens Research Institute
7/1/17 → 10/19/25
Project: Research project
-
Finished
Cystic Fibrosis Center Program FY24 - Pediatrics Portion
Kanga, J. (PI), Ramdial, F. (CoI), Thomas, T. (CoI) & Wurth, M. (CoI)
7/1/23 → 6/30/24
Project: Research project
-
Applying the ORBIT Model to Address Medical Trauma in Youth with CF
Marsac, M. (PI), Kanga, J. (CoI) & Wurth, M. (CoI)
6/1/23 → 5/31/24
Project: Research project
-
Cystic Fibrosis Center Program FY23 - Pediatrics Portion
Kanga, J. (PI), Danov, Z. (CoI) & Wurth, M. (CoI)
7/1/22 → 6/30/23
Project: Research project
-
FY24 Metabolic Newborn Screening
Zarate, Y. (PI), Day, S. (CoI), Fowlkes, J. (CoI), Kahler, S. (CoI), Kanga, J. (CoI), Radulescu, V. (CoI) & Wurth, M. (CoI)
KY Cabinet for Health and Family Services
7/1/22 → 6/30/24
Project: Research project
-
FY23 Metabolic Newborn Screening
Zarate, Y. (PI), Day, S. (CoI), Fowlkes, J. (CoI), Kahler, S. (CoI), Kanga, J. (CoI), Radulescu, V. (CoI) & Wurth, M. (CoI)
KY Cabinet for Health and Family Services
7/1/22 → 6/30/23
Project: Research project
-
Therapeutic Development Center FY23
Wurth, M. (PI), Anstead, M. (CoI), Danov, Z. (CoI), Kanga, J. (CoI) & Kuhn, R. (CoI)
4/1/22 → 3/31/23
Project: Research project
-
Therapeutic Development Center FY24
Wurth, M. (PI), Anstead, M. (CoI), Kanga, J. (CoI), Kuhn, R. (CoI), Ramdial, F. (CoI) & Danov, Z. (Former CoI)
4/1/22 → 6/30/24
Project: Research project
-
Cystic Fibrosis Center Program FY22 - Pediatrics Portion
Kanga, J. (PI), Danov, Z. (CoI) & Wurth, M. (CoI)
7/1/21 → 6/30/22
Project: Research project
-
Cystic Fibrosis Center Program FY21 - Pediatrics Portion
Kanga, J. (PI), Danov, Z. (CoI), Marsac, M. (CoI), Pancham, K. (CoI) & Wurth, M. (CoI)
7/1/20 → 6/30/21
Project: Research project
-
FY21 UK Metabolic Newborn Screening
Day, S. (PI), Kahler, S. (CoI), Kanga, J. (CoI), Radulescu, V. (CoI), Thrailkill, K. (CoI) & Wurth, M. (CoI)
KY Cabinet for Health and Family Services
7/1/20 → 6/30/21
Project: Research project
-
FY22 UK Metabolic Newborn Screening
Day, S. (PI), Fowlkes, J. (CoI), Kahler, S. (CoI), Kanga, J. (CoI), Radulescu, V. (CoI) & Wurth, M. (CoI)
KY Cabinet for Health and Family Services
7/1/20 → 6/30/22
Project: Research project
-
FY20 Metabolic Newborn Screening
Psychogios, A. (PI), Fowlkes, J. (CoI), Kanga, J. (CoI), Radulescu, V. (CoI) & Wurth, M. (CoI)
KY Cabinet for Health and Family Services
7/1/18 → 6/30/20
Project: Research project
-
FY19 Metabolic Newborn Screening
Day, S. (PI), Fowlkes, J. (CoI) & Kanga, J. (CoI)
KY Cabinet for Health and Family Services
7/1/18 → 6/30/19
Project: Research project
-
Cystic Fibrosis Center Program 2016-2017
Kanga, J. (PI), Anstead, M. (CoI), Danov, Z. (CoI) & Pancham, K. (CoI)
7/1/16 → 6/30/17
Project: Research project
-
FY18 Metabolic Newborn Screening
Amato, R. (PI), Kanga, J. (CoI) & Thrailkill, K. (CoI)
KY Cabinet for Health and Family Services
7/1/16 → 6/30/18
Project: Research project
-
Metabolic Newborn Screening - 2016
Amato, R. (PI), Kanga, J. (CoI) & Thrailkill, K. (CoI)
KY Department for Public Health
7/1/16 → 6/30/17
Project: Research project
-
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of N91115 to Evaluate Efficacy and Safety in Patients with Cystic Fibrosis who are Homozygous for the F508del-CFTR Mutation and Being Treated with lumacaftor/ivacaftor (ORKAMBI)
Anstead, M. (PI), Danov, Z. (CoI), Kanga, J. (CoI) & Tupayachi Ortiz, M. (CoI)
Nivalis Therapeutics Incorporated
9/30/15 → 8/30/17
Project: Research project
-
Cystic Fibrosis Center Program 2014-2015
Kanga, J. (PI) & Anstead, M. (CoI)
7/1/15 → 6/30/16
Project: Research project
-
Cystic Fibrosis Center Program--2014-2015
Kanga, J. (PI) & Anstead, M. (CoI)
7/1/14 → 6/30/15
Project: Research project
-
Metabolic Newborn Screening--FY 2015
Amato, R. (PI), Kanga, J. (CoI) & Smith, W. (CoI)
KY Cabinet for Health and Family Services
7/1/14 → 6/30/15
Project: Research project
-
Metabolic Newborn Screening
Amato, R. (PI), Kanga, J. (CoI) & Thrailkill, K. (CoI)
KY Cabinet for Health and Family Services
7/1/14 → 6/30/16
Project: Research project
-
Therapeutics Development Network 2014-2015
Anstead, M. (PI), Danov, Z. (CoI), Kanga, J. (CoI) & Kuhn, R. (CoI)
Cystic Fibrosis Foundation Therapeutics Incorporated
1/1/14 → 12/31/15
Project: Research project
-
Therapeutic Development Center FY2020
Pancham, K. (PI), Anstead, M. (CoI), Danov, Z. (CoI), Kanga, J. (CoI) & Kuhn, R. (CoI)
1/1/14 → 3/31/20
Project: Research project
-
Therapeutic Development Center FY2021
Pancham, K. (PI), Anstead, M. (CoI), Danov, Z. (CoI), Kanga, J. (CoI) & Kuhn, R. (CoI)
1/1/14 → 3/31/21
Project: Research project
-
Therapeutic Development Center FY2022
Wurth, M. (PI), Anstead, M. (CoI), Danov, Z. (CoI), Kanga, J. (CoI) & Kuhn, R. (CoI)
1/1/14 → 3/30/22
Project: Research project
-
Proof of Principal Evaluation of IV Gallium Nitrate (Ganite) in Patients with Cystic Fibrosis
Pancham, K. (PI), Danov, Z. (CoI), Kanga, J. (CoI), Anstead, M. (Former PI) & Tupayachi Ortiz, M. (Former PI)
Seattle Childrens Research Institute
9/1/13 → 6/30/18
Project: Research project
-
Cystic Fibrosis Center Program 2017-2018
Kanga, J. (PI), Anstead, M. (CoI), Danov, Z. (CoI) & Pancham, K. (CoI)
7/1/13 → 6/30/18
Project: Research project
-
Cystic Fibrosis FY 20 - Pediatrics Portion
Kanga, J. (PI), Danov, Z. (CoI), Pancham, K. (CoI) & Wurth, M. (CoI)
7/1/13 → 6/30/20
Project: Research project
-
Cystic Fibrosis Center Program 2019-2020 (PEDS Portion)
Kanga, J. (PI), Danov, Z. (CoI), Pancham, K. (CoI) & Wurth, M. (CoI)
7/1/13 → 6/30/19
Project: Research project
-
Cystic Fibrosis Center Program 2013-2014
Kanga, J. (PI) & Anstead, M. (CoI)
7/1/13 → 6/30/14
Project: Research project
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination with Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, omozygous for the F508del-CFTR Mutation
Anstead, M. (PI), Danov, Z. (CoI) & Kanga, J. (CoI)
6/20/13 → 6/30/15
Project: Research project
-
A phase 2, randomized, double blind, placebo-controlled study of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in cystic fibrosis patients (SAV005-02)
Danov, Z. (PI), Anstead, M. (CoI) & Kanga, J. (CoI)
3/13/13 → 3/31/15
Project: Research project
-
KaloBios CF KB001A-05 A Phase 2, Randomized Double-Blind, Placebo-Controlled, Repeat-dose Study of KB001A in Subjects with Cystic Fibrosis Infected withPseudomonas Aeruginosa
Danov, Z. (PI), Anstead, M. (CoI) & Kanga, J. (CoI)
KaloBios Pharmaceuticals Incorporated
10/30/12 → 10/30/14
Project: Research project
-
A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy
Anstead, M. (PI), Danov, Z. (CoI) & Kanga, J. (CoI)
Seattle Childrens Research Institute
10/22/12 → 9/30/20
Project: Research project
-
KaloBios Asthma Study KB003-04 Safety, Tolerability, and Efficacy
Anstead, M. (PI), Danov, Z. (CoI), Kanga, J. (CoI) & Khosravi, M. (CoI)
Chiltern International Incorporated
10/1/12 → 9/30/14
Project: Research project
-
VX12-770-112 / A Phase 3, Two-Arm, Rollover Study to Evaluate the Safety of Long-Term Ivacaftor Treatment in Subjects 6 Years of Age and Older
Anstead, M. (PI), Danov, Z. (CoI) & Kanga, J. (CoI)
9/1/12 → 8/30/14
Project: Research project
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects with Cystic Fibrosis who have the R117H-CFTR Mutation
Anstead, M. (PI), Danov, Z. (CoI) & Kanga, J. (CoI)
7/2/12 → 6/30/14
Project: Research project
-
Metabolic Newborn Screening
Wallace, C. (PI), Hong-McAtee, I. (CoI), Kanga, J. (CoI) & Anstead, M. (Former CoI)
KY Cabinet for Health and Family Services
7/1/12 → 6/30/13
Project: Research project
-
Metabolic Newborn Screening--FY 14
Amato, R. (PI) & Kanga, J. (CoI)
KY Cabinet for Health and Family Services
7/1/12 → 6/30/14
Project: Research project
-
Cystic Fibrosis Center Program
Kanga, J. (PI) & Anstead, M. (CoI)
7/1/12 → 6/30/13
Project: Research project
-
ALPINE Study
Danov, Z. (PI), Anstead, M. (CoI) & Kanga, J. (CoI)
11/4/11 → 11/3/13
Project: Research project
-
Cystic Fibrosis Center Progam
Kanga, J. (PI) & Anstead, M. (CoI)
7/1/11 → 6/30/12
Project: Research project
-
Mpex 209 Study
Anstead, M. (PI), Danov, Z. (CoI) & Kanga, J. (CoI)
6/22/11 → 7/1/13
Project: Research project